Olink Holding AB (publ) (OLK)

NASDAQ: OLK · IEX Real-Time Price · USD
17.08
+0.86 (5.30%)
At close: Jul 6, 2022 4:00 PM
16.30
-0.78 (-4.57%)
After-hours: Jul 6, 2022 7:30 PM EDT

Company Description

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research.

Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.

The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services.

In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data.

Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden.

Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.

Olink Holding AB (publ)
Country United States
Founded 2004
IPO Date Mar 25, 2021
Industry Diagnostics & Research
Sector Health Care
Employees 416

Contact Details

Address:
Uppsala Science Park
Uppsala 751 83
Sweden
Phone 46 1 84 44 39 70

Stock Details

Ticker Symbol OLK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
IPO Price $20.00
CIK Code 1835539
ISIN Number US6807101000
SIC Code 3826

Key Executives

Name Position
Jon Heimer Chief Executive Officer and Director
Oskar Hjelm Chief Financial Officer
Fredrik Netzel Chief Operating Officer
Dr. Ida Grundberg Ph.D. Chief Scientific Officer
Jan Medina CFA Vice President of Investor Relations and Capital Markets
Linda Ramirez-Eaves Esq. General Counsel
Andrea Prander Corporate Communications Manager
Johanna Isander Chief People Officer
Rickard El Tarzi Chief Strategy Officer
Carl Raimond Chief Commercial Officer

Latest SEC Filings

Date Type Title
Jun 1, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
May 12, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 7, 2022 S-8 Securities to be offered to employees in employee benefit plans
Apr 7, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 7, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 17, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 17, 2022 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 7, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 14, 2022 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022 SC 13G Statement of acquisition of beneficial ownership by individuals